ArticleScientific reports2021

Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment.

So Yeon Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.